Drug Type Aptamers |
Synonyms- |
Target |
Action inhibitors |
Mechanism NS3 inhibitors(Hepatitis C virus (HCV) nonstructural protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Zika Virus Infection | Preclinical | Brazil | 01 Feb 2026 |





